Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript
Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript
Sotera Health (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Sotera Health Company (SHC) Q4 Earnings and Revenues Beat Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript
Sotera Health Company ( SHC ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - Senior VP & CFO Conference Call Participants Patrick Donnelly - Citigroup Inc., Research Division Luke Sergott - Barclays Bank PLC, Research Division David Windley - Jefferies LLC, Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Jason Bednar - Piper Sandler & Co., Research Division Michael Polark - Wolfe Research, LLC Presentation Operator Good morning, and welcome to the Sotera Health Third Quarter 2025 Conference Call. [Operator Instructions] Please note this event is being recorded.
Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings
The headline numbers for Sotera Health (SHC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sotera Health Company (SHC) Q3 Earnings and Revenues Surpass Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.17 per share a year ago.
Should You Buy Sotera Health Company (SHC) After Golden Cross?
Sotera Health Company (SHC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SHC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Jonathan M. Lyons - Senior VP & CFO Michael B.
Exploring Analyst Estimates for Sotera Health (SHC) Q2 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sotera Health (SHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
